EUVIMEDEUVIMED entdecken
Crossref

Longitudinal [ 18 F]FMISO PET Evaluation of Hypoxic Tissue in a Rat Model of Hindlimb Ischemia

Noemí Gómez-Lado iD, David Rey-Bretal iD, Manuel Piñeiro-Fiel iD, Lucía Díaz-Platas iD, Santiago Medín-Aguerre iD, Anxo Fernández-Ferreiro iD, Álvaro Ruibal iD, Virginia Pubul iD, Diego Caicedo-Valdés iD, Pablo Aguiar iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.5c00994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Noemí Gómez-Lado und 9 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Biomarkers and Theragnosis Lab, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de C…. Hauptthemen laut MEDLINE: Hindlimb, Ischemia, Misonidazole, Peripheral Arterial Disease. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Instituto de Investigaci?n Sanitaria de Santiago de Compostela, Instituto de Salud Carlos III, Spanish Society of Angiology and Vascular Surgery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral artery disease (PAD) is a vascular condition caused by atherosclerosis that can reduce blood flow and occlude certain arteries. Hypoxia induces angiogenesis, leading to the proliferation and expansion of the capillary network, thereby reducing cellular ischemia. Several studies have suggested that hypoxia should be considered a major target for diagnosing and monitoring treatment of PAD. However, its in vivo detection in hindlimb ischemia models remains unexplored. In this preclinical study, hypoxia was assessed using longitudinal [18F]Fluoromisonidazole ([18F]FMISO) PET/CT imaging, in comparison with perfusion and glucose metabolism evaluated by [99mTc]Tetrofosmin ([99mTc]TTF) SPECT and [18F]Fluorodeoxyglucose ([18F]FDG) PET/CT, respectively, in a rat model of hindlimb ischemia. PAD was induced in 29 rats through the occlusion of the femoral, epigastric, popliteal, saphenous and iliac arteries in the left hind limb and longitudinal PET/CT and SPECT scans were conducted to assess disease progression postsurgery. Our results showed that the hindlimb ischemia rat model exhibited hypoxic tissue during the first 3 h postischemia, when the hypoxic volume reached its maximum. This volume then rapidly decreased over time, particularly after 26 h postsurgery. The hypoxic region exhibited a precise spatial overlap with the area of hypoperfusion; however, hypoperfusion was most pronounced during the first week postocclusion and gradually resolved between days 7 and 30. In contrast, [18F]FDG uptake showed a modest increase in the hypoxic region beginning at 3 days postischemia and appeared to persist beyond the period of hypoperfusion, remaining detectable up to 14 days postischemia. These findings demonstrate the presence of hypoxic tissue in the ischemic hindlimb and open the possibility for new therapies aimed at reducing ischemic damage associated with hindlimb ischemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HindlimbIschemiaMisonidazolePeripheral Arterial DiseaseHypoxiaAnimalsRatsDisease Models, AnimalMalePositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Organotechnetium CompoundsTomography, Emission-Computed, Single-PhotonRats, Sprague-DawleyRadiopharmaceuticalsPositron-Emission TomographyOrganophosphorus Compounds

Stichwörter der Autor:innen

Peripheral artery disease (PAD)SPECT/PET/CT imaging[18F]FMISOhypoxiaischemia

Substanzen

MisonidazolefluoromisonidazoleFluorodeoxyglucose F18Organotechnetium CompoundsRadiopharmaceuticalstechnetium tc-99m tetrofosminOrganophosphorus Compounds

Autor:innen und Institutionen

  • Molecular Imaging Biomarkers and Theragnosis Lab, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.
  • Molecular Imaging Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela 15706, Spain.
  • Nuclear Medicine Service, University Clinical Hospital of Santiago de Compostela (CHUS), Santiago de Compostela 15706, Spain.
  • Galician PET Radiopharmacy Unit, GALARIA, University Clinical Hospital of Santiago de Compostela (CHUS), Santiago de Compostela 15706, Spain.
  • FarmaCHUSLab, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela 15706, Spain.
  • Pharmacy Service, University Clinical Hospital of Santiago de Compostela (CHUS), Santiago de Compostela 15706, Spain.

ORCID-Profile: Noemí Gómez-Lado, David Rey-Bretal, Manuel Piñeiro-Fiel, Lucía Díaz-Platas, Santiago Medín-Aguerre, Anxo Fernández-Ferreiro, Álvaro Ruibal, Virginia Pubul, Diego Caicedo-Valdés, Pablo Aguiar

Förderung

  • Instituto de Investigaci?n Sanitaria de Santiago de Compostela
  • Instituto de Salud Carlos III
  • Spanish Society of Angiology and Vascular Surgery

Zitieren

APA

Gómez-Lado, N., Rey-Bretal, D., Piñeiro-Fiel, M., Díaz-Platas, L., Medín-Aguerre, S., Fernández-Ferreiro, A., Ruibal, Á., Pubul, V., Caicedo-Valdés, D., & Aguiar, P. (2026). Longitudinal [ 18 F]FMISO PET Evaluation of Hypoxic Tissue in a Rat Model of Hindlimb Ischemia. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00994

Vancouver

Gómez-Lado N, Rey-Bretal D, Piñeiro-Fiel M, Díaz-Platas L, Medín-Aguerre S, Fernández-Ferreiro A, et al. Longitudinal [ 18 F]FMISO PET Evaluation of Hypoxic Tissue in a Rat Model of Hindlimb Ischemia. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00994

BibTeX
@article{GmezLado2026,
  author = {Gómez-Lado, Noemí and Rey-Bretal, David and Piñeiro-Fiel, Manuel and Díaz-Platas, Lucía and Medín-Aguerre, Santiago and Fernández-Ferreiro, Anxo and Ruibal, Álvaro and Pubul, Virginia and Caicedo-Valdés, Diego and Aguiar, Pablo},
  title = {Longitudinal [ 18 F]FMISO PET Evaluation of Hypoxic Tissue in a Rat Model of Hindlimb Ischemia},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.5c00994}
}
Kostenlos starten →